Skip to main content

Table 1 Demographic and Clinical characteristics and outcomes of males on ART screened for gynecomastia (N = 1432)

From: Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe

Characteristic All (N = 1432) Gynecomastia (n = 73)
Demographics
 Age (years), median (IQR) 40 (38–48) 40 (33–48)
 Baseline CD4 count median (IQR) 260 (126–412) 318 (192–469)
 Baseline BMI, median (IQR) 21 (19–24) 21 (19–23)
 Baseline WHO (%)
  Stage 1 548 (50) 28 (48)
  Stage 2 217 (20) 14 (24)
  Stage 3 233 (21) 10 (17)
  Stage 4 97 (9) 6 (10)
  Follow up time (years), median (IQR) 1.7 (1.0–2.6)  
Presentation of gynecomastia
 Unilateral   28 (38)
 Bilateral   43 (59)
 Unknown   2 (3)
Outcomes
 Complete resolution   28 (38)
 Partial resolution   43 (59)
 Non resolution   2 (3)
 Unknown   5 (7)
  1. IQR interquartile range, WHO World Health Organization Staging